Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients

Clinical trial NCT01837511 · COMPLETED

Trial details

NCT number: NCT01837511
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)

Start date: 2007-08-01
Primary completion: 2008-01-01
Enrollment: 377

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.